Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.33 |
| ▸ | RAB9A | P51151 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL5196978 | 0.98 | TSHR (0.39) | TSHRACHETRPA1ATMGAA | |
| Hydrochloric Acid SCHEMBL154108 | 0.98 | TSHR (0.39) | TSHRACHETRPA1ATMGAA | |
| Hydrochloric Acid SCHEMBL31150435 | 0.98 | TSHR (0.39) | TSHRACHETRPA1ATMGAA | |
| Hydrochloric Acid SCHEMBL3327763 | 0.96 | TSHR (0.38) | TSHRACHETRPA1ATMGAA | |
| SCHEMBL753567 | 0.91 | TSHR (0.41) | TSHRACHETRPA1ATMGAA | |
| Water SCHEMBL28584406 | 0.88 | TSHR (0.39) | TSHRACHETRPA1ATMGAA | |
| Hydrochloric Acid SCHEMBL4373437 | 0.88 | TSHR (0.39) | TSHRACHETRPA1ATMGAA | |
| Sulfuric Acid SCHEMBL2110043 | 0.88 | GAA (0.36) | TSHRACHETRPA1ATMGAA | |
| Formic Acid SCHEMBL5197972 | 0.88 | ALDH1A1 (0.36) | TSHRACHETRPA1ATMGAA | |
| Acetic Acid SCHEMBL5196852 | 0.88 | GAA (0.40) | TRPA1GAAALDH1A1PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2431359-B1 | Process for preparing diaminophenothiazinium compounds | PROVEPHARM LIFE SOLUTIONS (FR) | 2020-06-03 | — | — | EP | claimed |
| EP-2046767-B1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVENCE TECHNOLOGIES (FR) | 2015-04-22 | — | — | EP | claimed |
| US-20150056160-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. | 2015-02-26 | — | — | US | claimed |
| CN-102596967-A | Photochemical process for producing artemisinin | SANOFI AVENTIS | 2012-07-18 | — | — | CN | claimed |
| EP-2431359-A1 | Process for preparing diaminophenothiazinium compounds | Provence Technologies (FR) | 2012-03-21 | — | — | EP | claimed |
| US-20100056643-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST. JUDE PHARMACEUTICALS, INC. | 2010-03-04 | — | — | US | claimed |
| EP-2046767-A2 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | Provence Technologies (FR) | 2009-04-15 | — | — | EP | claimed |
| WO-2008006979-A2 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVENCE TECHNOLOGIES (FR) | 2008-01-17 | — | — | WO | claimed |
| EP-1647543-B1 | A method for inhibiting polymerization of (Meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor | ROHM & HAAS (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1098641-A4 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2003-08-27 | — | — | EP | claimed |
| EP-1098641-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | Texas Pharmaceuticals, Inc. (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000006143-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
| EP-2913327-B1 | Methylene blue and its medical use | PROVEPHARM LIFE SOLUTIONS (FR) | 2023-06-07 | — | — | EP | disclosed |
| CN-105683389-B | Method for specifically labeling live bacteria comprising use of modified monosaccharide compounds | 国家科学研究中心 | 2021-09-28 | — | — | CN | disclosed |
| EP-2431359-B1 | Process for preparing diaminophenothiazinium compounds | PROVEPHARM LIFE SOLUTIONS (FR) | 2020-06-03 | — | — | EP | disclosed |
| CN-107848992-A | Method for chemically synthesizing substituted 10H-phenothiazine-3, 7-diamine compound | 维斯塔实验室有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-20060074257-A1 | Method for inhibiting polymerization of (meth)acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor | BASS STEPHEN | 2006-04-06 | — | — | US | disclosed |
| EP-1098641-A4 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | ST JUDE PHARMACEUTICALS INC (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1098641-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | Texas Pharmaceuticals, Inc. (US) | 2001-05-16 | — | — | EP | disclosed |
| WO-2000006143-A1 | CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA | TEXAS PHARMACEUTICALS, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074257-A1 | Method for inhibiting polymerization of (meth)acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor | MMAB, AZI2, MEP1A | TSHR 4161/4885ACHE 1933/4885TRPA1 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.